Rystiggo needs marketing strategy to fully compete in myasthenia gravis space, says GlobalData
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
New deal strengthens Congenica’s presence in India
Subscribe To Our Newsletter & Stay Updated